Using aid to finance coronavirus vaccine research may violate OECD rules
Donors have committed large amounts to a multi-billion-dollar aid-financed initiative to develop vaccines against coronavirus. The OECD says this vaccine would benefit rich countries as much as poor countries and it may not allow contributions to be reported as aid.
